Research on the Conceptual Boundaries and Connotations of Accessibility to Novel Anticancer Drugs Based on Value Orientation
- VernacularTitle:基于价值导向的抗肿瘤创新药物可及性概念界定与内涵研究
- Author:
Hong ZHU
1
;
Hongwei CHEN
;
Ya LI
;
Meixiang GAO
;
Yiru YIN
;
Jia'an YANG
;
Haohao FENG
;
Qunhong WU
Author Information
1. 哈尔滨医科大学人文社会科学学院 黑龙江 哈尔滨 150086
- Publication Type:Journal Article
- Keywords:
anticancer drug policy;
drug accessibility;
novel anticancer drugs;
concept definition;
value-based healthcare
- From:
Chinese Health Economics
2025;44(6):7-12
- CountryChina
- Language:Chinese
-
Abstract:
Objective:Based on value orientation,it aimed to scientifically define the concept and connotation of accessibility to novel anticancer drugs,in order to deeply understand the nature and current status of the accessibility issues of novel anticancer drugs,and to provide a reference for the formulation and optimization of policies related to novel anticancer drugs.Methods:Data was collected through literature review and expert interviews,and the concept of drug accessibility was defined using the atomic diagram method.Results:The core images include"affordability","availability","high quality"and"patients".The concept of accessibility to novel anticancer drugs is defined as"the process of ensuring the sustainable supply,equitable access,affordability,and rational use of high-quality anticancer drugs to safeguard the realization of patient benefit goals."The connotation of the value orientation in policies on the accessibility of novel anticancer drugs is profoundly reflected in the multi-dimensional value-driven approach to ensure the ultimate benefit of patients,which includes quality,sustainability,equity,affordability,and rational use.Conclusion:The proposal of the concept and connotation of accessibility provides a theoretical basis for a deep understanding of the accessibility of novel anticancer drugs and offers valuable references for subsequent policy-making and practical operations.
